Olaparib is under clinical development by AstraZeneca and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II drugs for Malignant Mesothelioma have a 42% phase ...

ZW-171 is under clinical development by Zymeworks and currently in Phase I for Malignant Mesothelioma. According to GlobalData, Phase I drugs for Malignant Mesothelioma have a 74% phase transition ...

The role of surgery for malignant pleural mesothelioma encompasses the need for rapid diagnosis, preoperative staging and surgical resection, and also the need for a greater biological ...

Although life-threatening and incurable, mesothelioma is not always fatal. Many patients have become long-term survivors.

Asbestos exposure in the workplace can deliver deadly health consequences. It can cause injury or disease, adding to the risk ...

for the first-line treatment of adult patients with unresectable non-epithelioid malignant pleural mesothelioma (MPM). Pleural mesothelioma is a type of cancer that develops in the tissue that ...

New York: The McGraw-Hill Company, 2009. Sugarbaker DJ, Norberto JJ, Swanson SJ. Surgical staging and work-up of patients with diffuse malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg.

At present, education is not considered a high-risk industry for malignant mesothelioma. Off Education employees do not fit the typical patient profile of mesothelioma and asbestos exposure. Despite ...

Purpose The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line ...